Literature DB >> 8262824

Pituitary adenomas: long-term results for radiotherapy alone and post-operative radiotherapy.

M N Hughes1, K J Llamas, M E Yelland, L B Tripcony.   

Abstract

PURPOSE: Analysis of prognostic factors and long-term results of treatment of pituitary adenomas. METHODS AND MATERIALS: The study involved a retrospective review of outcome in a series of 268 patients with pituitary adenomas, treated at the Queensland Radium Institute from January 1962 to December 1986. The study population included 108 patients treated with radiotherapy alone and 160 patients treated by surgery and post-operative radiotherapy. In each group, univariate and multivariate analyses were conducted of possible prognostic factors including age, sex, performance status, tumor type, tumor extent, visual disturbance, radiotherapy dose, and field size.
RESULTS: For radiotherapy alone, the 10-year progression-free survival rate was 60%, and overall tumor control was obtained in 77%. Univariate analysis suggested that tumor type and radiotherapy field size were of prognostic significance. Multivariate analysis confirmed that Prolactinoma subtype and increasing radiotherapy field size were independently predictive of reduced progression-free survival. Long-term visual complications occurred in 1% of patients treated by radiotherapy alone. In patients treated by surgery and post-operative radiotherapy, the 10-year progression-free survival rate was 77%, and overall tumor control was achieved in 83%. Univariate analysis suggested that tumor type, completeness of surgical excision, and radiotherapy dose were predictive of outcome. However, on multivariate analysis, only the extent of surgical excision predicted prognosis independently. Long-term visual sequelae were noted in 3% of patients treated by surgery and post-operative radiotherapy.
CONCLUSION: Both radiotherapy alone and post-operative radiotherapy are effective in long-term control of pituitary adenomas, and produce acceptably low complication rates.

Entities:  

Mesh:

Year:  1993        PMID: 8262824     DOI: 10.1016/0360-3016(93)90520-6

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

Review 1.  Neurology of the pituitary gland.

Authors:  J R Anderson; N Antoun; N Burnet; K Chatterjee; O Edwards; J D Pickard; N Sarkies
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-06       Impact factor: 10.154

2.  Evaluation of modern pathologic nomenclature, tumor imaging and treatment of pituitary adenomas in a recent surgical series.

Authors:  A Y Cheung; T Sligh; S Bauserman; G Schultz
Journal:  J Neurooncol       Date:  1998-04       Impact factor: 4.130

Review 3.  The role of radiation therapy in the management of non-functioning pituitary adenomas.

Authors:  M Losa; P Picozzi; M Motta; M Valle; A Franzin; P Mortini
Journal:  J Endocrinol Invest       Date:  2011-03-22       Impact factor: 4.256

4.  Postoperative radiation therapy for pituitary adenoma.

Authors:  K Isobe; M Ohta; S Yasuda'; T Uno; R Hara; N Machida; N Saeki; A Yamaura; N Shigematsu; H Ito
Journal:  J Neurooncol       Date:  2000-06       Impact factor: 4.130

5.  Stereotactic Radiosurgery with the CyberKnife for Pituitary Adenomas.

Authors:  Chul Bum Cho; Hae Kwan Park; Won Il Joo; Chung Kee Chough; Kyung Jin Lee; Hyoung Kyun Rha
Journal:  J Korean Neurosurg Soc       Date:  2009-03-31

6.  The role of the le fort I maxillotomy in the management of incompletely resected pituitary macroadenomas.

Authors:  Bruce Mickey; Leslie Hutchins; Edward Ellis
Journal:  Skull Base       Date:  2007-11

7.  Radiotherapy for pituitary adenomas: long-term outcome and complications.

Authors:  Chai Hong Rim; Dae Sik Yang; Young Je Park; Won Sup Yoon; Jung Ae Lee; Chul Yong Kim
Journal:  Radiat Oncol J       Date:  2011-09-30

Review 8.  Radiation therapy for Cushing's disease: a review.

Authors:  Ashraf S Mahmoud-Ahmed; John H Suh
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

9.  Should cancer survivors fear radiation-induced sarcomas?

Authors:  M Feigen
Journal:  Sarcoma       Date:  1997
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.